inhibitor < inhibitors < inhibitory

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f KwdFr.f Mesh.f MeshFr.f Teeft.f

List of bibliographic references indexed by inhibitors

Number of relevant bibliographic references: 57.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000078 (2020)	Mahmoud Kandeel [Arabie saoudite] ; Mizuki Yamamoto [Japon] ; Abdulla Al-Taher [Arabie saoudite] ; Aya Watanabe [Japon] ; Kentaro Oh-Hashi [Japon] ; Byoung Kwon Park [Corée du Sud] ; Hyung-Joo Kwon [Corée du Sud] ; Jun-Ichiro Inoue [Japon] ; Mohammed Al-Nazawi [Arabie saoudite]	Small Molecule Inhibitors of Middle East Respiratory Syndrome Coronavirus Fusion by Targeting Cavities on Heptad Repeat Trimers.
000098 (2020)	Thanigaimalai Pillaiyar [Allemagne] ; Sangeetha Meenakshisundaram [Inde] ; Manoj Manickam [Inde]	Recent discovery and development of inhibitors targeting coronaviruses
000227 (2020)	Nashwa Hafez Zaher [Égypte] ; Mohammed Ismail Mostafa [Égypte] ; Abdullah Yousef Altaher	Design, synthesis and molecular docking of novel triazole derivatives as potential CoV helicase inhibitors.
000295 (2020)	Abdo A. Elfiky	Anti-HCV, nucleotide inhibitors, repurposing against COVID-19
000501 (2019)	Md Mostafijur Rahman [Bangladesh] ; Md Bayejid Hosen [Bangladesh] ; M Zakir Hossain Howlader [Bangladesh] ; Yearul Kabir [Bangladesh]	Lead Molecule Prediction and Characterization for Designing MERS-CoV 3C-like Protease Inhibitors: An In silico Approach.
000537 (2019)	Hyun Lee ; Jinhong Ren ; Russell P. Pesavento ; Isabel Ojeda ; Amy J. Rice ; Haining Lv ; Youngjin Kwon ; Michael E. Johnson	Identification and design of novel small molecule inhibitors against MERS-CoV papain-like protease via high-throughput screening and molecular modeling
000549 (2019)	Liang Shen [République populaire de Chine] ; Junwei Niu [République populaire de Chine] ; Chunhua Wang [République populaire de Chine] ; Baoying Huang [République populaire de Chine] ; Wenling Wang [République populaire de Chine] ; Na Zhu [République populaire de Chine] ; Yao Deng [République populaire de Chine] ; Huijuan Wang [République populaire de Chine] ; Fei Ye [République populaire de Chine] ; Shan Cen [République populaire de Chine] ; Wenjie Tan [Oman]	High-Throughput Screening and Identification of Potent Broad-Spectrum Inhibitors of Coronaviruses.
000667 (2019)	Seri Jo ; Hyojin Kim ; Suwon Kim ; Dong Hae Shin ; Mi-Sun Kim	Characteristics of flavonoids as potent MERS‐CoV 3C‐like protease inhibitors
000754 (2018-01-31)	Quentin Nevers [France]	Development of a new family of cyclophilin inhibitors with broad antiviral spectrum and study of their mechanisms of action in Hepatitis C Virus and Coronavirus infections.
000795 (2018)	Anushka C. Galasiti Kankanamalage [États-Unis] ; Yunjeong Kim [États-Unis] ; Vishnu C. Damalanka [États-Unis] ; Athri D. Rathnayake [États-Unis] ; Anthony R. Fehr [États-Unis] ; Nurjahan Mehzabeen [États-Unis] ; Kevin P. Battaile [États-Unis] ; Scott Lovell [États-Unis] ; Gerald H. Lushington [États-Unis] ; Stanley Perlman [États-Unis] ; Kyeong-Ok Chang [États-Unis] ; William C. Groutas [États-Unis]	Structure-guided design of potent and permeable inhibitors of MERS coronavirus 3CL protease that utilize a piperidine moiety as a novel design element
000818 (2018)	Ji Yeun Kim [Corée du Sud] ; Young Il Kim [Corée du Sud] ; So Jung Park [Corée du Sud] ; In Ki Kim [Corée du Sud] ; Young Ki Choi [Corée du Sud] ; Sung-Han Kim [Corée du Sud]	Safe, high-throughput screening of natural compounds of MERS-CoV entry inhibitors using a pseudovirus expressing MERS-CoV spike protein
000A03 (2018)	Chao Wang [République populaire de Chine] ; Shuai Xia [République populaire de Chine] ; Peiyu Zhang [République populaire de Chine] ; Tianhong Zhang [République populaire de Chine] ; Weicong Wang [République populaire de Chine] ; Yangli Tian [République populaire de Chine] ; Guangpeng Meng [République populaire de Chine] ; Shibo Jiang [République populaire de Chine, États-Unis] ; Keliang Liu [République populaire de Chine]	Discovery of Hydrocarbon-Stapled Short α-Helical Peptides as Promising Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Fusion Inhibitors
000A08 (2018)	Ruiying Liang ; Lili Wang ; Naru Zhang ; Xiaoqian Deng ; Meng Su ; Yudan Su ; Lanfang Hu ; Chen He ; Tianlei Ying [République populaire de Chine] ; Shibo Jiang [République populaire de Chine] ; Fei Yu	Development of Small-Molecule MERS-CoV Inhibitors
000A26 (2018)	Jeanne M. Sisk [États-Unis] ; Matthew B. Frieman [États-Unis] ; Carolyn E. Machamer [États-Unis]	Coronavirus S protein-induced fusion is blocked prior to hemifusion by Abl kinase inhibitors.
000B39 (2017)	Wahiba Aouadi [France] ; Cécilia Eydoux [France] ; Bruno Coutard [France] ; Baptiste Martin [France] ; Françoise Debart [France] ; Jean Jacques Vasseur [France] ; Jean Marie Contreras [France] ; Christophe Morice [France] ; Gilles Quérat [France] ; Marie-Louise Jung [France] ; Bruno Canard [France] ; Jean-Claude Guillemot [France] ; Etienne Decroly [France]	Toward the identification of viral cap-methyltransferase inhibitors by fluorescence screening assay
000C26 (2017)	Wei-Ming Chai [République populaire de Chine] ; Mei-Zhen Lin [République populaire de Chine] ; Hui-Ling Feng [République populaire de Chine] ; Zheng-Rong Zou [République populaire de Chine] ; Ying-Xia Wang [République populaire de Chine]	Proanthocyanidins purified from fruit pericarp of Clausena lansium (Lour.) Skeels as efficient tyrosinase inhibitors: structure evaluation, inhibitory activity and molecular mechanism.
000E45 (2017)	Shan Su [République populaire de Chine] ; Yun Zhu [République populaire de Chine] ; Sheng Ye [République populaire de Chine] ; Qianqian Qi [République populaire de Chine] ; Shuai Xia [République populaire de Chine] ; Zhenxuan Ma [République populaire de Chine] ; Fei Yu [République populaire de Chine] ; Qian Wang [République populaire de Chine] ; Rongguang Zhang [République populaire de Chine] ; Shibo Jiang [République populaire de Chine] ; Lu Lu [République populaire de Chine]	Creating an Artificial Tail Anchor as a Novel Strategy To Enhance the Potency of Peptide-Based HIV Fusion Inhibitors.
001045 (2016)	Haofeng Wang ; Song Xue ; Haitao Yang ; Cheng Chen	Recent progress in the discovery of inhibitors targeting coronavirus proteases
001212 (2016)	Vathan Kumar [Taïwan] ; Kian-Pin Tan [Taïwan] ; Ying-Ming Wang [Taïwan] ; Sheng-Wei Lin [Taïwan] ; Po-Huang Liang [Taïwan]	Identification, synthesis and evaluation of SARS-CoV and MERS-CoV 3C-like protease inhibitors
001312 (2016)	Fenghua Wang [République populaire de Chine] ; Cheng Chen [République populaire de Chine] ; Xuemeng Liu [République populaire de Chine] ; Kailin Yang [États-Unis] ; Xiaoling Xu [République populaire de Chine] ; Haitao Yang [République populaire de Chine]	Crystal Structure of Feline Infectious Peritonitis Virus Main Protease in Complex with Synergetic Dual Inhibitors.
001393 (2016)	Christopher M. Coleman [États-Unis] ; Jeanne M. Sisk [États-Unis] ; Rebecca M. Mingo [États-Unis] ; Elizabeth A. Nelson [États-Unis] ; Judith M. White [États-Unis] ; Matthew B. Frieman [États-Unis]	Abelson Kinase Inhibitors Are Potent Inhibitors of Severe Acute Respiratory Syndrome Coronavirus and Middle East Respiratory Syndrome Coronavirus Fusion.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "inhibitors" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i  \
                -Sk "inhibitors" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    MersV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Title.i
   |clé=    inhibitors
}}

---

This area was generated with Dilib version V0.6.33. Data generation: Mon Apr 20 23:26:43 2020. Site generation: Sat Mar 27 09:06:09 2021